Molecular characterisation of a rabbit Hepatitis E Virus strain detected in a chronically HEV-infected individual from Germany.

"table 3 co20 (%) co05 (%) co01 (%) plasma (rahev-83) v1479i (98 1) g1634k (99 9) stool (rahev-99) k1383n (96 3) v1479i (98 9 ) g1634k (99 9) d1384g (7 5) k1383s (3 7) d1384n (4 3) k1398r (1 2) substitutions associated with rbv resistance in hev-3 are underlined co = cut-off 3 3 phylogenetic analysis of the full-length sequences of rahev-83 and rahev-99 was performed together with hev references sequences as proposed by smith et al [ ] and all available full-length rahev sequences from genbank.; the sequences generated in this study are available at the national center for biotechnology information (ncbi) genbank under the accession numbers listed in the material and methods section (op909735 and op909736)."

"Declaration of Competing Interest The authors declare that they have no known competing financial interest and personal relationship that could inappropriately influence the presented work."

"Funding This study was supported by a grant from the German 10.13039/501100003107Federal Ministry of Health (BMG) regarding a decision of the German Bundestag by the Federal Government (NiCaDe-Project Phase I and II, grant No: ZMVI-2519GHP711, and CHED-Project grant No: ZMVI1-2518FSB705). D.H. is supported by the 10.13039/100007570Claussen-Simon-Stiftung (10.13039/100007570Claussen-Simon Foundation; CSF) “Dissertation Plus” program, Germany, and the Fazit-Stiftung “Promotions Stipendium”. B.A. is supported by ProFIT grant of the Investitionsbank Berlin, Germany (IBB, ProFIT No. 10169028 / co-funded by EFRE (No. 10169096)). The funders BMG, CSF, Fazit, and ProFit had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The content is the responsibility only of the authors and does not represent the views of the funders."